Two Sigma Advisers’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-80,400
Closed -$421K 2223
2025
Q4
$421K Sell
80,400
-38,700
-32% -$153K ﹤0.01% 1855
2025
Q3
$516K Buy
119,100
+19,000
+19% +$34.2K ﹤0.01% 1753
2025
Q2
$105K Buy
100,100
+13,200
+15% +$15.8K ﹤0.01% 2203
2025
Q1
$112K Buy
86,900
+74,100
+579% +$117K ﹤0.01% 2227
2024
Q4
$32K Buy
+12,800
New +$45.6K ﹤0.01% 2313

Other funds holding ZURA

Two Sigma Advisers's ZURA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 80,400 shares — an estimated $421K sold.

Two Sigma Advisers first reported a position in ZURA in Q4 2024 and held it in 5 quarters. The position peaked at $516K in Q3 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 80,400 Zura Bio shares in Q1 2026, an estimated $421K.
  • Two Sigma Advisers first reported a position in Zura Bio in Q4 2024 and held it in 5 quarters.
  • Two Sigma Advisers's Zura Bio position peaked at $516K in Q3 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.